CEO
InsuLife
The startup is developing a spray-based insulin delivery system that eliminates the need for traditional needle injections, providing a convenient and painless alternative for diabetics. This method enhances patient compliance and accessibility to insulin therapy, making it more affordable and effective for managing diabetes.
- Digital Health
- Healthcare Technology
- Medical Devices
Updated 6 months ago
Funding
Raised to date
$2.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup is developing a spray-based insulin delivery system that eliminates the need for traditional needle injections, providing a convenient and painless alternative for diabetics. This method enhances patient compliance and accessibility to insulin therapy, making it more affordable and effective for managing diabetes.